Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Net Income towards Common Stockholders: 2019-2025

Historic Net Income towards Common Stockholders for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to $16.8 million.

  • Burning Rock Biotech's Net Income towards Common Stockholders fell 91.19% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 106.92%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • Burning Rock Biotech's Net Income towards Common Stockholders amounted to $16.8 million in Q3 2025, which was up 182.30% from -$20.5 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Net Income towards Common Stockholders ranged from a high of $614.6 million in Q4 2022 and a low of -$231.4 million during Q3 2022.
  • In the last 3 years, Burning Rock Biotech's Net Income towards Common Stockholders had a median value of -$20.5 million in 2025 and averaged $327,909.
  • The largest annual percentage gain for Burning Rock Biotech's Net Income towards Common Stockholders in the last 5 years was 1,609.78% (2022), contrasted with its biggest fall of 775.17% (2022).
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Net Income towards Common Stockholders stood at -$40.7 million in 2021, then skyrocketed by 1,609.78% to $614.6 million in 2022, then tumbled by 35.33% to $397.4 million in 2023, then slumped by 102.07% to -$8.2 million in 2024, then slumped by 91.19% to $16.8 million in 2025.
  • Its Net Income towards Common Stockholders stands at $16.8 million for Q3 2025, versus -$20.5 million for Q2 2025 and -$13.1 million for Q1 2025.